Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Allergy to beta-lactams

Rakesh Chandra

    Expert Opinion on Drug Safety
    |March 1, 2006
    PubMed
    Summary

    No abstract available in PubMed .

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Postnatal Care Utilisation Among Adolescent Mothers in India: A Pooled Cross-Sectional Study of NFHS-4 and NFHS-5.

    Public health challenges·2026
    Same author

    Trends in self-reported reproductive tract infections and treatment-seeking behaviour among Indian women, 2005-2021.

    Reproductive health·2026
    Same author

    Air Quality Index Association With Cytokine Inflammatory Markers in Chronic Rhinosinusitis.

    International forum of allergy & rhinology·2026
    Same author

    Investigating the Chronic Rhinosinusitis Inflammatory Profile of Traffic-Associated Air Pollution.

    Ear, nose, & throat journal·2026
    Same author

    Exploring the association between indoor air pollution (IAP) and anaemia among pregnant women in India.

    PloS one·2026
    Same author

    Managing menstruation on the move: a qualitative study of menstrual hygiene management practices and health challenges among female ticket collectors in India.

    Culture, health & sexuality·2026
    Same journal

    Could anticholinergics accelerate ALS progression? A critical perspective on drug safety and disease vulnerability.

    Expert opinion on drug safety·2026
    Same journal

    Safety profile of teprotumumab-trbw, the first and only FDA-approved treatment for thyroid-associated ophthalmopathy.

    Expert opinion on drug safety·2026
    Same journal

    A systematic review and meta-analysis of safety and efficacy parameters of sotatercept in the therapy of pulmonary arterial hypertension.

    Expert opinion on drug safety·2026
    Same journal

    Tirzepatide data: safety first is safety always!

    Expert opinion on drug safety·2026
    Same journal

    An update on the safety of biologics for the treatment of psoriasis.

    Expert opinion on drug safety·2026
    Same journal

    Recent advances in trastuzumab and its antibody-drug conjugates-related liver injury.

    Expert opinion on drug safety·2026
    See all related articles